Janux Therapeutics Inc. is a leading biotechnology company focused on the development of innovative cancer immunotherapies. With a mission to improve patient outcomes, the company utilizes cutting-edge technologies to create targeted therapies that harness the power of the immune system to fight cancer. Their dedicated team of scientists and researchers strive to bring new treatment options to patients in need.
Notification